These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9180626)
1. Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat. Rosenthal T; Erlich Y; Rosenmann E; Cohen A Hypertension; 1997 Jun; 29(6):1260-4. PubMed ID: 9180626 [TBL] [Abstract][Full Text] [Related]
2. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Tomiyama H; Kushiro T; Abeta H; Ishii T; Takahashi A; Furukawa L; Asagami T; Hino T; Saito F; Otsuka Y Hypertension; 1994 Apr; 23(4):450-5. PubMed ID: 8144214 [TBL] [Abstract][Full Text] [Related]
4. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats. Schnecko A; Witte K; Lemmer B J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045 [TBL] [Abstract][Full Text] [Related]
5. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats. Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285 [TBL] [Abstract][Full Text] [Related]
6. Chronic converting enzyme inhibition facilitates baroreceptor resetting to hypertensive levels. da Silva VJ; da Silva SV; Salgado MC; Salgado HC Hypertension; 1994 Jan; 23(1 Suppl):I68-72. PubMed ID: 8282378 [TBL] [Abstract][Full Text] [Related]
7. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men. Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. Tikkanen I; Omvik P; Jensen HA J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133 [TBL] [Abstract][Full Text] [Related]
10. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360 [TBL] [Abstract][Full Text] [Related]
11. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450 [TBL] [Abstract][Full Text] [Related]
12. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan. Demeilliers B; Jover B; Mimran A J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648 [TBL] [Abstract][Full Text] [Related]
13. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Gansevoort RT; de Zeeuw D; de Jong PE Kidney Int; 1994 Mar; 45(3):861-7. PubMed ID: 8196289 [TBL] [Abstract][Full Text] [Related]
14. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. Lafayette RA; Mayer G; Park SK; Meyer TW J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models. Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170 [TBL] [Abstract][Full Text] [Related]
17. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension. Byyny RL; Merrill DD; Bradstreet TE; Sweet CS Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats. Foucart S; Patrick SK; Oster L; de Champlain J Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708 [TBL] [Abstract][Full Text] [Related]
20. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Keith DS; Torres VE; Johnson CM; Holley KE Am J Kidney Dis; 1994 Sep; 24(3):491-8. PubMed ID: 8079975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]